B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Proteoglycan 4

300 PubMed studies analyzed · Evidence Score: 43.8

Research Domains

Proteoglycan 4 has been studied across 16 research domains including 🦴 Bone & Joint, 🔬 Oncology, 🔬 Inflammation, ✨ Skin & Hair, 🛡️ Immunity. The primary research focus is 🦴 Bone & Joint with 32% of studies addressing this area.

Loading evidence profile...

This evidence profile for Proteoglycan 4 is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.